List of Attending Speakers | 2023

  • Devang Bhuva, Senior Vice President, Corporate Development, Gilead Sciences
  • Alex Burgin, Director of the Center for the Development of Therapeutics, Broad Institute of MIT and Harvard
  • Mira Chaurushiya, Senior Partner, Westlake Village Partners
  • Marianne De Backer, Head of Strategy, Business Development & Licensing and Open Innovation and Member of the Executive Committee, Bayer
  • Niels Emmerich, VP Global Head, Search & Evaluation, AbbVie
  • Dan Estes, General Partner, Frazier Healthcare Partners
  • Angus Grant, Chief Business Executive, BeiGene
  • David Greenwald, Vice President, Business Development, Deerfield Management
  • Jason Hafler, Managing Director, Sanofi Ventures
  • Catriona Jamieson, Deputy Director, Professor of Medicine and Chief, Division of Regenerative Medicine, UC San Diego Health
  • Rachna Khosla, Senior Vice President, Business Development, Amgen
  • Chau Khuong, General Partner and Senior Advisor, Catalio Capital Management
  • Nina Kjellson, General Partner, Canaan Partners
  • Angela Kujak, Head of Office of Strategic Alliances and Partnerships, Broad Institute
  • Jennifer Leeds, Executive Director, Head NIBR BD&L Search and Evaluation, West Coast and Canada, Novartis
  • Jay Lichter, Managing Director, Avalon Ventures; President and CEO, Arialys Therapeutics
  • Tim Luker, Vice President, Venture Science, West Coast USA Head, Corp BD, Eli Lilly
  • Detlev Mennerich, Corporate SVP, Global Head of Business Development & Licensing, Boehringer Ingelheim
  • Carole Nuechterlein, Head, Roche Venture Fund
  • Michele Park, Partner, New Enterprise Associates (NEA)
  • Sunil Patel, Senior Vice President & Head of Corporate Development, Merck
  • Camille Samuels, Partner, Venrock
  • Andy Schwab, Founder and Managing Partner, 5AM Ventures
  • Matt Trembley, COO, Scripps Research Institute and Calibr
  • Issei Tsukamoto, SVP, Head of Business Development, Astellas Pharma
  • John Reed, EVP, Global Head of Research & Development, Sanofi
  • Uwe Schoenbeck, Senior Vice President and CSO, Emerging Science and Innovation, Pfizer Worldwide Research Development and Medical
  • DA Wallach, General Partner, Co-Founder, Time BioVentures
  • Jeffrey W Warmke, Ph.D., Senior Advisor, Global Business Development, Daiichi Sankyo Group